The disease is often preceded by a premalignant condition (MBL) which shares most molecular motorists with overt CLL. In many situations, these molecular drivers continue being continual with time. Having said that, clonal evolution can be possible and is frequently related to exponential tumor expansion, progressive illness and, in some instances,